Rapport Therapeutics, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2023 | $14.5M | $155.4M | $70.2M |
| FY2024 | $9.5M | $314.9M | $56.8M |
| FY2025 | $27.8M | $512.4M | $52.6M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2023 | $14.5M | $155.4M | $70.2M |
| FY2024 | $9.5M | $314.9M | $56.8M |
| FY2025 | $27.8M | $512.4M | $52.6M |